Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Lantheus Holdings (NASDAQ: LNTH), a leading radiopharmaceutical company, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. CEO Brian Markison will present on Wednesday, September 4, at 7:45 a.m. ET.
Investors and interested parties can access a live webcast of the presentation through the Investors section of Lantheus' website at www.lantheus.com. The company will make a replay of the webcast available on its website for at least 30 days following the live presentation.
This conference participation underscores Lantheus' commitment to engaging with the investment community and sharing insights into its business focused on enabling clinicians to Find, Fight and Follow disease for improved patient outcomes.
Lantheus Holdings (NASDAQ: LNTH), una delle principali aziende di radiofarmaceutici, ha annunciato la sua partecipazione alla 22ª Conferenza Annuale sulla Salute Globale di Morgan Stanley. Il CEO Brian Markison presenterà mercoledì 4 settembre alle 7:45 a.m. ET.
Investitori e parti interessate possono accedere a una webcast dal vivo della presentazione attraverso la sezione Investitori del sito web di Lantheus all'indirizzo www.lantheus.com. L'azienda metterà a disposizione una registrazione della webcast sul suo sito per almeno 30 giorni dopo la presentazione dal vivo.
Questa partecipazione alla conferenza sottolinea l'impegno di Lantheus nel coinvolgere la comunità degli investitori e condividere informazioni sulla propria attività focalizzata su consentire ai medici di Trovare, Combattere e Seguire la malattia per migliorare i risultati per i pazienti.
Lantheus Holdings (NASDAQ: LNTH), una empresa líder en radiofármacos, ha anunciado su participación en la 22ª Conferencia Anual de Salud Global de Morgan Stanley. El CEO Brian Markison presentará el miércoles 4 de septiembre a las 7:45 a.m. ET.
Los inversores y partes interesadas pueden acceder a una transmisión web en vivo de la presentación a través de la sección de Inversores en el sitio web de Lantheus en www.lantheus.com. La empresa hará una repetición de la transmisión disponible en su sitio durante al menos 30 días después de la presentación en vivo.
Esta participación en la conferencia subraya el compromiso de Lantheus de interactuar con la comunidad inversora y compartir información sobre su negocio centrado en permitir a los clínicos Encontrar, Luchar y Seguir la enfermedad para mejorar los resultados de los pacientes.
Lantheus Holdings (NASDAQ: LNTH), 선도적인 방사선약품 회사가 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. CEO인 브라이언 마키슨이 9월 4일 수요일 오전 7시 45분 ET에 발표할 예정입니다.
투자자 및 관심 있는 분들은 라이브 웹캐스트를 통해 Lantheus 웹사이트의 투자자 섹션에서 발표를 시청할 수 있습니다: www.lantheus.com. 이 회사는 라이브 발표 후 30일 이상 웹캐스트 재방송을 웹사이트에서 제공할 예정입니다.
이번 컨퍼런스 참가로 Lantheus는 투자 커뮤니티와의 소통과 의료진이 질병을 찾아내고, 싸우고, 추적하는 것을 지원하는 것에 대한 비전을 공유하려는 의지를 강조하고 있습니다.
Lantheus Holdings (NASDAQ: LNTH), une entreprise leader dans le secteur des radio-pharmaceutiques, a annoncé sa participation à la 22e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley. Le PDG Brian Markison fera une présentation le mercredi 4 septembre à 7h45 ET.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la section Investisseurs du site web de Lantheus à www.lantheus.com. L'entreprise proposera une rediffusion du webinaire sur son site pendant au moins 30 jours suivant la présentation en direct.
Cette participation à la conférence souligne l'engagement de Lantheus à interagir avec la communauté des investisseurs et à partager ses perspectives sur son activité, qui vise à permettre aux médecins de Trouver, Combattre et Suivre les maladies pour améliorer les résultats des patients.
Lantheus Holdings (NASDAQ: LNTH), ein führendes Unternehmen im Bereich der Radiopharmazeutika, hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley bekannt gegeben. CEO Brian Markison wird am Mittwoch, den 4. September um 7:45 Uhr ET präsentieren.
Investoren und interessierte Parteien können über den Investorenbereich der Website von Lantheus auf eine Live-Übertragung der Präsentation zugreifen unter www.lantheus.com. Das Unternehmen wird die Aufzeichnung der Übertragung für mindestens 30 Tage nach der Live-Präsentation auf seiner Website zur Verfügung stellen.
Diese Konferenzteilnahme unterstreicht das Engagement von Lantheus, mit der Investoren-Community in Kontakt zu treten und Einblicke in sein Geschäft zu teilen, das darauf abzielt, Ärzten zu helfen, Krankheiten zu finden, zu bekämpfen und zu verfolgen, um die Ergebnisse für die Patienten zu verbessern.
- None.
- None.
BEDFORD, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Brian Markison, Chief Executive Officer, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference at 7:45 a.m. ET on Wednesday, September 4.
To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Senior Director, External Communications
646-975-2533
media@lantheus.com
FAQ
When is Lantheus (LNTH) presenting at the Morgan Stanley Healthcare Conference?
Who will be representing Lantheus (LNTH) at the Morgan Stanley Healthcare Conference?
How can investors access Lantheus' (LNTH) presentation at the Morgan Stanley conference?
For how long will the replay of Lantheus' (LNTH) presentation be available?
What is Lantheus' (LNTH) main focus as a company?
